Kissei Pharmaceutical Co., Ltd. (TYO: 4547)
Japan
· Delayed Price · Currency is JPY 3,445.00
-65.00 (-1.85%)
Dec 20, 2024, 3:45 PM JST
Kissei Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 147,464 | 156,266 | 121,792 | 117,826 | 112,984 | 129,918 | Upgrade
|
| Market Cap Growth | 0.93% | 28.31% | 3.37% | 4.29% | -13.03% | -4.04% | Upgrade
|
| Enterprise Value | 99,876 | 115,492 | 77,037 | 78,311 | 68,996 | 78,100 | Upgrade
|
| Last Close Price | 3445.00 | 3491.00 | 2547.45 | 2388.65 | 2240.12 | 2489.13 | Upgrade
|
| PE Ratio | 14.25 | 14.00 | 11.57 | 9.12 | 21.38 | 46.12 | Upgrade
|
| Forward PE | 14.67 | 14.26 | 10.90 | 36.67 | 28.42 | 40.81 | Upgrade
|
| PS Ratio | 1.89 | 2.07 | 1.80 | 1.80 | 1.64 | 2.05 | Upgrade
|
| PB Ratio | 0.69 | 0.71 | 0.63 | 0.58 | 0.51 | 0.67 | Upgrade
|
| P/TBV Ratio | 0.72 | 0.72 | 0.63 | 0.59 | 0.52 | 0.68 | Upgrade
|
| P/FCF Ratio | 186.66 | - | - | 2677.87 | - | 9.95 | Upgrade
|
| P/OCF Ratio | 45.67 | - | - | 76.86 | - | 9.32 | Upgrade
|
| EV/Sales Ratio | 1.23 | 1.53 | 1.14 | 1.20 | 1.00 | 1.24 | Upgrade
|
| EV/EBITDA Ratio | 12.08 | 13.96 | 25.97 | 33.64 | 14.83 | 17.67 | Upgrade
|
| EV/EBIT Ratio | 26.41 | 28.75 | - | - | 45.81 | 42.06 | Upgrade
|
| EV/FCF Ratio | 126.43 | - | - | 1779.80 | - | 5.98 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.15 | 0.16 | 0.50 | 0.70 | 0.37 | 0.40 | Upgrade
|
| Debt / FCF Ratio | 1.59 | - | - | 37.27 | - | 0.13 | Upgrade
|
| Asset Turnover | 0.33 | 0.31 | 0.29 | 0.26 | 0.28 | 0.28 | Upgrade
|
| Inventory Turnover | 1.60 | 1.56 | 1.68 | 1.75 | 2.16 | 2.07 | Upgrade
|
| Quick Ratio | 3.98 | 4.17 | 4.79 | 4.01 | 3.70 | 4.65 | Upgrade
|
| Current Ratio | 5.50 | 5.92 | 6.73 | 5.30 | 5.10 | 5.68 | Upgrade
|
| Return on Equity (ROE) | 5.11% | 5.43% | 5.36% | 6.17% | 2.60% | 1.54% | Upgrade
|
| Return on Assets (ROA) | 0.96% | 1.04% | -0.31% | -0.35% | 0.38% | 0.52% | Upgrade
|
| Return on Capital (ROIC) | 1.11% | 1.20% | -0.36% | -0.41% | 0.45% | 0.61% | Upgrade
|
| Earnings Yield | 7.02% | 7.14% | 8.64% | 10.97% | 4.68% | 2.17% | Upgrade
|
| FCF Yield | 0.54% | -1.84% | -7.21% | 0.04% | -3.07% | 10.05% | Upgrade
|
| Dividend Yield | 2.61% | 2.35% | 3.14% | 2.34% | 2.41% | 2.09% | Upgrade
|
| Payout Ratio | 34.39% | 33.35% | 29.78% | 19.63% | 46.83% | 84.56% | Upgrade
|
| Buyback Yield / Dilution | 3.52% | 1.86% | - | 1.18% | 0.11% | - | Upgrade
|
| Total Shareholder Return | 6.13% | 4.21% | 3.14% | 3.53% | 2.52% | 2.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.